162 related articles for article (PubMed ID: 12149235)
1. Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantation.
Lapierre V; Aupérin A; Tayebi H; Chabod J; Saas P; Michalet M; François S; Garban F; Giraud C; Tramalloni D; Oubouzar N; Blaise D; Kuentz M; Robinet E; Tiberghien P;
Blood; 2002 Aug; 100(4):1484-9. PubMed ID: 12149235
[TBL] [Abstract][Full Text] [Related]
2. Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantation.
Lapierre V; Oubouzar N; Aupérin A; Tramalloni D; Tayebi H; Robinet E; Kuentz M; Blaise D; Hartmann O; Hervé P; Tiberghien P;
Blood; 2001 May; 97(9):2580-6. PubMed ID: 11313245
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of curative efficacy after G-CSF-mobilized sibling HLA-matched peripheral blood hematopoietic stem cell transplantation versus that combined with BMT for patients with hematologic malignancies in a single center].
Ren FP; Liu HL; Sun ZM; Geng LQ; Wang XB; Ding KY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):404-9. PubMed ID: 21518497
[TBL] [Abstract][Full Text] [Related]
4. Blood versus marrow hematopoietic allogeneic graft.
Robinet E; Lapierre V; Tayebi H; Kuentz M; Blaise D; Tiberghien P
Transfus Apher Sci; 2003 Aug; 29(1):53-9. PubMed ID: 12877895
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease.
Pan L; Teshima T; Hill GR; Bungard D; Brinson YS; Reddy VS; Cooke KR; Ferrara JL
Blood; 1999 Jun; 93(12):4071-8. PubMed ID: 10361103
[TBL] [Abstract][Full Text] [Related]
6. Transplant Outcomes in Beta-Thalassemia Major Patients Receiving Combined Granulocyte Colony-Stimulating Factor-Primed Bone Marrow and Cord Blood Graft Compared to Granulocyte Colony-Stimulating Factor-Primed Bone Marrow Alone.
Wen J; Haque Q; Pei F; Chen L; Ruan Y; Liu X; He Y; Feng X; Li C; Wu X
Acta Haematol; 2018; 140(1):20-29. PubMed ID: 30071526
[TBL] [Abstract][Full Text] [Related]
7. The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation.
Ji SQ; Chen HR; Xun CQ; Wang HX; Pan SP; Xiao MH
Clin Transplant; 2001 Oct; 15(5):317-23. PubMed ID: 11678957
[TBL] [Abstract][Full Text] [Related]
8. Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.
Arseniev L; Tischler HJ; Battmer K; Südmeier I; Casper J; Link H
Bone Marrow Transplant; 1994 Nov; 14(5):791-7. PubMed ID: 7534162
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-mobilized bone marrow.
Arcese W; De Angelis G; Cerretti R
Curr Opin Hematol; 2012 Nov; 19(6):448-53. PubMed ID: 22954729
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic peripheral blood stem cell transplantation results in less alteration of early T cell compartment homeostasis than bone marrow transplantation.
Tayebi H; Tiberghien P; Ferrand C; Lienard A; Duperrier A; Cahn JY; Lapierre V; Saas P; Kuentz M; Blaise D; Hervé P; Robinet E;
Bone Marrow Transplant; 2001 Jan; 27(2):167-75. PubMed ID: 11281386
[TBL] [Abstract][Full Text] [Related]
12. Transfusions of granulocyte-colony-stimulating factor-mobilized granulocyte components to allogeneic transplant recipients: analysis of kinetics and factors determining posttransfusion neutrophil and platelet counts.
Adkins D; Spitzer G; Johnston M; Velasquez W; Dunphy F; Petruska P
Transfusion; 1997 Jul; 37(7):737-48. PubMed ID: 9225939
[TBL] [Abstract][Full Text] [Related]
13. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
15. Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow.
Benboubker L; Cartron G; Roingeard F; Delain M; Degenne M; Linassier C; Hérault O; Truglio D; Bout M; Petit A; Brémond JL; Desbois I; Colombat P; Binet C; Domenech J
Exp Hematol; 2003 Jan; 31(1):89-97. PubMed ID: 12543111
[TBL] [Abstract][Full Text] [Related]
16. Improved outcomes using G-CSF-mobilized blood and bone marrow grafts as the source of stem cells compared with G-PB after HLA-identical sibling transplantation in patients with acute leukemia.
Zhao XS; Chen Y; Zhao XY; Liu DH; Xu LP; Wang Y; Han W; Chen YH; Chen H; Zhang XH; Liu KY; Huang XJ
Clin Transplant; 2013; 27(6):844-51. PubMed ID: 23992032
[TBL] [Abstract][Full Text] [Related]
17. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.
Pavletic ZS; Bishop MR; Tarantolo SR; Martin-Algarra S; Bierman PJ; Vose JM; Reed EC; Gross TG; Kollath J; Nasrati K; Jackson JD; Armitage JO; Kessinger A
J Clin Oncol; 1997 Apr; 15(4):1608-16. PubMed ID: 9193360
[TBL] [Abstract][Full Text] [Related]
19. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
20. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia.
Mavroudis DA; Read EJ; Molldrem J; Raptis A; Plante M; Carter CS; Phang S; Dunbar CE; Barrett AJ
Bone Marrow Transplant; 1998 Mar; 21(5):431-40. PubMed ID: 9535034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
